Arcutis Biotherapeutics, Inc.

ARQT · Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

Arcutis Biotherapeutics, Inc. (ARQT), in the Healthcare sector, has 38 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 10 corporate insiders: 2 purchases and 36 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 15 and filed Sep 17. The most active filer was Howard G. Welgus with 20 filings.

Add to watchlist

Filings, ttm

2 buys · 36 sells

Traders, ttm

1 congress · 10 insiders

Volume, ttmiDollar value disclosed in the window

$15.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 15

Filed Sep 17

ADViAverage daily dollar volume

$51.3M

market data

Share price · 12M

$25.38 (+46.1%)

Adjusted for splits and dividends.

Volume by month

Buys $16K Sells $21.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Howard G. Welgus Director 20 filings PB

Patrick Burnett See Remarks 11 filings TW

Todd Watanabe See Remarks 9 filings MM

Masaru Matsuda See Remarks 7 filings TW

Todd Franklin Watanabe See Remarks 5 filings GC

Gilbert Cisneros Representative 3 filings LE

Larry Todd Edwards See Remarks 2 filings SL

Sue-jean Lin Director 2 filings

Recent filings

Howard G. WelgusSALE Director $114K
4,730 sh × $24.18
Exec Sep 15
Filed Sep 17 · 4:06 PM ET Masaru MatsudaSALE See Remarks $250K
9,989 sh × $25.03
Exec Sep 8
Filed Sep 10 · 7:24 PM ET Terrie CurranSALE Director $956K
38,200 sh across 2 lots
Exec Aug 27
Filed Aug 28 · 5:40 PM ET Howard G. WelgusSALE Director $124K
4,730 sh × $26.18
Exec Aug 17
Filed Aug 19 · 4:57 PM ET Patrick BurnettSALE See Remarks $395K
15,000 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 8:06 PM ET Todd WatanabeSALE See Remarks $114K
4,375 sh × $26.12
Exec Aug 3
Filed Aug 5 · 9:42 PM ET Howard G. WelgusSALE Director $127K
4,730 sh × $26.91
Exec Jul 15
Filed Jul 17 · 4:01 PM ET Sue-jean LinSALE Director $121K
4,946 sh × $24.38
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec May 29
Filed Jun 8 Masaru MatsudaSALE See Remarks $172K
7,372 sh × $23.27
Exec May 4
Filed May 6 · 5:30 PM ET Howard G. WelgusSALE Director $164K
7,144 sh × $22.99
Exec May 1
Filed May 5 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec Mar 3
Filed Apr 7 Howard G. WelgusSALE Director $239K
10,000 sh × $23.88
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Howard G. WelgusSALE Director $256K
10,000 sh × $25.65
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Keith R LeonardSALE Director $997K
39,272 sh × $25.39
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Patrick BurnettSALE See Remarks $154K
6,106 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Masaru MatsudaSALE See Remarks $165K
6,553 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Todd WatanabeSALE See Remarks $913K
36,281 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Howard G. WelgusSALE Director $250K
10,000 sh × $25.05
Exec Feb 2
Filed Feb 4 · 5:30 PM ET Todd WatanabeSALE See Remarks $506K
19,833 sh × $25.50
Exec Feb 2
Filed Feb 4 · 5:30 PM ET Patrick BurnettSALE See Remarks $253K
9,794 sh × $25.81
Exec Feb 4
Filed Feb 4 · 5:30 PM ET Masaru MatsudaSALE See Remarks $1.0M
40,638 sh across 4 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET Gilbert CisnerosSALE Representative $8K
$1K–15K bracket
Exec Dec 11 2025
Filed Jan 12 Howard G. WelgusSALE Director $290K
10,000 sh × $28.96
Exec Jan 2
Filed Jan 6 · 5:30 PM ET Patrick BurnettSALE See Remarks $333K
11,500 sh × $28.94
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET